We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

News · September 07, 2021

ESC 2021: Stopping Dual Antiplatelet Therapy 1 Month After Percutaneous Coronary Intervention is Not Safe in Acute Coronary Syndromes

A reduction is bleeding risk was inadequate to offset the increased risk of myocardial infarction

PracticeUpdate Editorial Team


Further Reading